Search results for: Mikel Berdud
Filter search results
As UN General Assembly Highlights Tuberculosis Fight, Will BRICS Lead on the R&D Agenda?
26 September 2018
…on the CGD website and can be accessed here. Ferraro, J., Towse, A., and Mestre-Ferrandiz, J. 2017. Incentives for New Drugs to Tackle Anti-Microbial Resistance. OHE briefing. RePEc Berdud, M.,…
OHE at the ISPOR Summit on New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare October, 2018
5 November 2018
…and social care. Extending the scope of patient reported outcomes and QALYs from Office of Health Economics Related research: Berdud, M., Drummond, M., & Towse, A. (2018)….
Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Not So Fast…
28 March 2019
…resources to buy better together? The views expressed in this blog post are those of the authors and do not represent those of any institution. Berdud, M., Chalkidou, K., Dean,…
Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Five Questions We Think Matter a Lot
29 March 2019
…represent those of any institution. Berdud, M., Chalkidou, K., Dean, E., Ferraro, J., Garrison, L., Nemzoff, C., Towse, A. (2019). The Future of Global Health Procurement: Issues around Pricing Transparency….
Does Government Funding Increase Public Sector Development of New Medicines?
5 March 2021
…from: https://data.worldbank.org/indicator/GB.XPD.RSDV.GD.ZS?name_desc=false. [Accessed: March 3, 2021) Berdud, M., Drummond, M. and Towse, A., 2020. Establishing a reasonable price for an orphan drug. Cost Effectiveness and Resource Allocation, 18(1), p.31. 10.1186/s12962-020-00223-x….
The WHO Technical Report on the Pricing of Cancer Medicines: Missing a Central Role for Value Assessment
8 April 2019
…Missing a Central Role for HTA and Value Assessment. OHE Research Paper, London: Office of Health Economics. Berdud, M., Chalkidou, K., Dean, E., Ferraro, J., Garrison, L., Nemzoff, C. and…
A Final MVAC Blueprint—and the Start of an R&D Revolution?
6 February 2020
…for a Market-Driven Value-Based Advance Commitment (MVAC) for Tuberculosis. Draft for Consultation. Center for Global Development. Available at: https://www.cgdev.org/sites/default/files/MVAC-Blueprint-for-Consultation-2019-02-28.pdf Berdud, M., Chalkidou, K., Dean, E., Ferraro, J., Garrison, L., Nemzoff, C., Towse, A….
The Broader Value of Existing Vaccines in the Fight Against COVID-19: Beware of Tunnel Vision
8 October 2020
…at: https://www.ohe.org/publications/meningococcal-vaccines-international-comparison-decisionmaking-processes-frameworks Berdud, M., Towse, A., Jofre-Bonet, M., 2020. The Economics of Innovation in Times of Pandemic: How to Incentivise the Development, Supply, and Continuous Improvement of Innovative Solutions to…